102 related articles for article (PubMed ID: 16804386)
1. Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-cell transplant recipients?
Leather HL; Wingard JR
Curr Opin Infect Dis; 2006 Aug; 19(4):371-9. PubMed ID: 16804386
[TBL] [Abstract][Full Text] [Related]
2. Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.
Kontoyiannis DP; Ratanatharathorn V; Young JA; Raymond J; Laverdière M; Denning DW; Patterson TF; Facklam D; Kovanda L; Arnold L; Lau W; Buell D; Marr KA
Transpl Infect Dis; 2009 Feb; 11(1):89-93. PubMed ID: 18983417
[TBL] [Abstract][Full Text] [Related]
3. Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?
Muñoz P; Singh N; Bouza E
Curr Opin Infect Dis; 2006 Aug; 19(4):365-70. PubMed ID: 16804385
[TBL] [Abstract][Full Text] [Related]
4. Decision making in antifungal monotherapy versus combination therapy.
Lewis RE
Pharmacotherapy; 2006 Jun; 26(6 Pt 2):61S-67S. PubMed ID: 16716124
[TBL] [Abstract][Full Text] [Related]
5. Combination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients.
Singh N; Pursell KJ
Mycoses; 2008 Mar; 51(2):99-108. PubMed ID: 18254745
[TBL] [Abstract][Full Text] [Related]
6. Invasive aspergillosis: diagnosis, prophylaxis and treatment.
Del Bono V; Mikulska M; Viscoli C
Curr Opin Hematol; 2008 Nov; 15(6):586-93. PubMed ID: 18832929
[TBL] [Abstract][Full Text] [Related]
7. Combination antifungal therapy: a critical review of the evidence.
Ostrosky-Zeichner L
Clin Microbiol Infect; 2008 May; 14 Suppl 4():65-70. PubMed ID: 18430131
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
[TBL] [Abstract][Full Text] [Related]
9. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
Oshima K; Kanda Y; Asano-Mori Y; Nishimoto N; Arai S; Nagai S; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
J Antimicrob Chemother; 2007 Aug; 60(2):350-5. PubMed ID: 17584800
[TBL] [Abstract][Full Text] [Related]
10. Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation.
Salman N; Törün SH; Budan B; Somer A
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):307-15. PubMed ID: 21417870
[TBL] [Abstract][Full Text] [Related]
11. [Aspergillosis in stem cell transplant recipients].
Jantunen E
Duodecim; 2001; 117(17):1715-9. PubMed ID: 12181934
[No Abstract] [Full Text] [Related]
12. Combination antifungals: an update.
Segal BH; Steinbach WJ
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):883-92. PubMed ID: 17914921
[TBL] [Abstract][Full Text] [Related]
13. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine.
Chamilos G; Kontoyiannis DP
Curr Opin Infect Dis; 2006 Aug; 19(4):380-5. PubMed ID: 16804387
[TBL] [Abstract][Full Text] [Related]
14. Antifungal combination therapy for invasive aspergillosis.
Martín-Peña A; Aguilar-Guisado M; Espigado I; Cisneros JM
Clin Infect Dis; 2014 Nov; 59(10):1437-45. PubMed ID: 25048847
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy for invasive mycoses: evaluation of past clinical trial designs.
Sobel JD
Clin Infect Dis; 2004 Oct; 39 Suppl 4():S224-7. PubMed ID: 15546122
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
17. Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies.
Sipsas NV; Kontoyiannis DP
Clin Infect Dis; 2006 Jun; 42(11):1584-91. PubMed ID: 16652316
[TBL] [Abstract][Full Text] [Related]
18. Animal models testing monotherapy versus combination antifungal therapy: lessons learned and future directions.
Clemons KV; Stevens DA
Curr Opin Infect Dis; 2006 Aug; 19(4):360-4. PubMed ID: 16804384
[TBL] [Abstract][Full Text] [Related]
19. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
[TBL] [Abstract][Full Text] [Related]
20. New approaches to invasive fungal infections in acute leukemia and hematopoietic stem cell transplant patients.
Wingard JR
Best Pract Res Clin Haematol; 2007 Mar; 20(1):99-107. PubMed ID: 17336260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
